1921
Volume 93, Issue 2
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

There is no abstract available for this article.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.15-0302
2015-08-05
2017-11-18
Loading full text...

Full text loading...

/deliver/fulltext/14761645/93/2/210.html?itemId=/content/journals/10.4269/ajtmh.15-0302&mimeType=html&fmt=ahah

References

  1. Qiu X, Audet J, Wong G, Fernando L, Bello A, Pillet S, Alimonti JB, Kobinger GP, , 2013. Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAb. Sci Rep 3: 3365.
  2. U.S. Food and Drug Administration, Expanded Access (Compassionate Use), 2015. Available at: http://www.fda.gov/NewsEvents/PublicHealthFocus/ExpandedAccessCompassionateUse/ucm431774.htm. Accessed March 22, 2015.
  3. Lyon GM, Mehta AK, Varkey JB, Brantly K, Plyler L, McElroy AK, Kraft CS, Towner JS, Spiropoulou C, Ströher U, Uyeki TM, Ribner BS, , 2014. Emory serious communicable diseases unit. Clinical care of two patients with Ebola virus disease in the United States. N Engl J Med 371: 24022409.[Crossref]
  4. WHO, 2014. Ethical Considerations for Use of Unregistered Interventions for Ebola Virus Disease (EVD). Summary of the Panel Discussion. Available at: http://www.who.int/mediacentre/news/statements/2014/ebola-ethical-review-summary/en/.
  5. Pollack A, , 2014. Opting against Ebola Drug for Ill African Doctor. New York Times. Available at: http://www.nytimes.com/2014/08/13/world/africa/ebola.html?_r=1.
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.15-0302
Loading
  • Received : 18 Apr 2015
  • Accepted : 22 Apr 2015

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error